Merck helps FDA test blockchain for track and trace

There has been a lot of talk about how blockchain computer technology can better protect the U.S. drug supply chain. Merck & Co. intends to test that theory.

The U.S. drugmaker has been invited by the FDA, along with Walmart, IBM and KPMG, to make up a pilot project team to see how blockchain might help drugmakers secure their supply chains and fulfill the requirements of the 2015 Drug Supply Chain Security Act.